BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19816675)

  • 1. Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity.
    Hoque KE; Indorkar RP; Sammut S; West AR
    Psychopharmacology (Berl); 2010 Jan; 207(4):571-81. PubMed ID: 19816675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.
    Sammut S; Bray KE; West AR
    Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of striatal nitric oxide synthesis by local dopamine and glutamate interactions.
    Park DJ; West AR
    J Neurochem; 2009 Dec; 111(6):1457-65. PubMed ID: 19799710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors.
    Marti M; Mela F; Bianchi C; Beani L; Morari M
    J Neurochem; 2002 Nov; 83(3):635-44. PubMed ID: 12390525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release.
    Morris BJ; Simpson CS; Mundell S; Maceachern K; Johnston HM; Nolan AM
    Neuropharmacology; 1997; 36(11-12):1589-99. PubMed ID: 9517430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrical stimulation of the hippocampal fimbria facilitates neuronal nitric oxide synthase activity in the medial shell of the rat nucleus accumbens: Modulation by dopamine D1 and D2 receptor activation.
    Hoque KE; Blume SR; Sammut S; West AR
    Neuropharmacology; 2017 Nov; 126():151-157. PubMed ID: 28887183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.
    Keefe KA; Gerfen CR
    Neuroscience; 1995 Jun; 66(4):903-13. PubMed ID: 7651617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.
    Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS
    J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal cortical afferents facilitate striatal nitric oxide transmission in vivo via a NMDA receptor and neuronal NOS-dependent mechanism.
    Sammut S; Park DJ; West AR
    J Neurochem; 2007 Nov; 103(3):1145-56. PubMed ID: 17666041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated cocaine administration increases nitric oxide efflux in the rat dorsal striatum.
    Lee DK; Koh WC; Shim YB; Shim I; Choe ES
    Psychopharmacology (Berl); 2010 Feb; 208(2):245-56. PubMed ID: 19936712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic and cholinergic regulation of Fyn tyrosine kinase phosphorylation in the rat striatum in vivo.
    Mao LM; Wang JQ
    Neuropharmacology; 2015 Dec; 99():491-9. PubMed ID: 26277342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis.
    West AR; Grace AA
    J Neurosci; 2002 Jan; 22(1):294-304. PubMed ID: 11756513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation.
    Wersinger C; Chen J; Sidhu A
    Mol Cell Neurosci; 2004 Jan; 25(1):124-37. PubMed ID: 14962746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.